Speech-Language Pathologists in Tierra Verde, FL Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Marge H Dunkle, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 722 Pinellas Bayway S, 107, Tierra Verde, FL 33715 Phone: 727-804-1864

Patricia A Ludlow Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 443 Pinellas Bayway S, Unit 102, Tierra Verde, FL 33715 Phone: 727-867-1272

Pediatric Feeding And Swallowing Associates Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 137 1st St W, Tierra Verde, FL 33715 Phone: 727-317-7655    Fax: 727-279-4977

News Archive

Research links participation in team sports to larger hippocampal volumes in children

Adult depression has long been associated with shrinkage of the hippocampus, a brain region that plays an important role in memory and response to stress. Now, new research from Washington University in St. Louis has linked participation in team sports to larger hippocampal volumes in children and less depression in boys ages 9 to 11.

Pediatric patients who receive quick antibiotics for fever, neutropenia have reduced PICU needs

A University of Colorado Cancer Center study published in the journal Pediatric Blood & Cancer shows that pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and showing neutropenia (low neutrophil count), go on to have decreased intensive care consultation rate and lower mortality compared with patients who receive antibiotics outside the 60-minute window.

BioXpress, AET BioTech enter agreement to co-develop Adalimumab biosimilar

AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioXpress Therapeutics SA, a Swiss-based biotechnology company developing monoclonal antibody (MAb) biosimilars have entered into an agreement for the co-development of a biosimilar version of the TNF inhibitor MAb Adalimumab.

ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction

A novel study from Karolinska Institutet in Sweden suggests that commonly used drugs to treat heart failure and high blood pressure may have a wider range of application than earlier known, and also can be used against so called HFPEF - a type of heart failure that until now has been impossible to treat.

MU researcher finds four antiviral drugs effective in inhibiting novel coronavirus

Now, a researcher at the University of Missouri has found that four antiviral drugs, including remdesivir, a drug originally developed to treat Ebola, are effective in inhibiting the replication of the coronavirus causing COVID-19.

Read more Medical News

› Verified 7 days ago